The Recall Desk
Agency classClass IOur severity:SevereFDA (Devices)·Z-1898-2013·Announced 2013-08-21

Nova Max Glucose Test Strips Recalled for False High Readings

Nova Biomedical is recalling Nova Max Glucose Test Strips because they may produce false abnormally high glucose readings.

The agency’s classification

FDA (Devices): Class I

Class I is a situation in which there is a reasonable probability that the use of or exposure to a violative product will cause serious adverse health consequences or death.

This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work

What this means for you

Our assessment, not the agency’s: severity 4/5 (Severe).

The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.

Our severity reasoning: The agency classified this recall as Class I — a situation in which there is a reasonable probability that the use of or exposure to a violative product will cause serious adverse health consequences or death. On that classification alone this is scored Severe; a score of Critical is reserved for recalls where a death or serious injury was reported. The agency gives the reason as: "Reports of false abnormally high glucose readings from test strips"

Plain-English summary

Nova Biomedical Corporation is recalling approximately 32,452,700 Nova Max Glucose Test Strips (50 Count DME), Catalog Number 43523. The recall is due to reports of false abnormally high glucose readings from the test strips.

These test strips are intended for use with the Nova Max Family of Glucose Monitors (Nova Max, Nova Max Plus, Nova Max Link, BD Logic, and Paradigm Link) for the quantitative measurement of glucose in fresh capillary whole blood. They are used by people with diabetes mellitus in the home and by healthcare professionals in clinical settings to monitor the effectiveness of diabetes control.

The affected units were distributed nationwide in the United States and in Chile, England, Peru, and Nicaragua. Specific lot numbers and expiration dates are listed in the source document. Consumers should stop using the affected test strips and contact Nova Biomedical Corporation for instructions on how to return the product.

The recalled product

Product
Nova Max Glucose Test Strips (50 Count DME) Catalog Number: 43523 Product Usage: The Nova Max Glucose Test Strips are for use with the Nova Max Family of Glucose Monitors (Nova Max, Nova Max Plus, Nova Max Link, BD Logic and Paradigm Link). These monitors are intended to…
Affected units
32,452,700

Distribution

Distributed nationwide across the United States.

Part of a larger recall action

This product is one of 10 recalled by Nova Biomedical Corporation under a single FDA (Devices) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.

See all 10 products in this recall →

Similar recalls